BioCentury

1:43 AM GMT, Apr 26, 2008
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Top Story

Isis off on mipomersen delay

Isis (NASDAQ:ISIS) fell $4.81 (29%) to $11.99 on Friday after it and partner Genzyme (NASDAQ:GENZ) announced delayed regulatory timelines for mipomersen. The partners

Read the full 231 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.